Zhang, X., Ma, Y., Sun, Y., Cao, Y.-B., Li, Q. and Xu, C.-A. (2017) Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis. Targeted Oncology, 12, 309-321.
https://doi.org/10.1007/s11523-017-0486-5

has been cited by the following article:

• TITLE: Application Progress of Intravoxel Incoherent Motion Diffusion Weighted Magnetic Resonance Imaging in Pancreatic Cancer

  AUTHORS: Lili Xu, Boxu Ren

  KEYWORDS: Magnetic Resonance Imaging, Intravoxel Incoherent Motion, Diffusion Weighted Imaging, Pancreatic Disease

  JOURNAL NAME: Yangtze Medicine, Vol.5 No.1, January 8, 2021

  ABSTRACT: Intravoxel incoherent motion imaging (IVIM), on the traditional diffusion weighted imaging (DWI) technology, uses the biexponential model and adopts the multi-b-value analysis to obtain the perfusion information of water molecule diffusion and microcirculation without the use of contrast agent. It is more and more used in pancreatic diseases, which is of great significance for the diagnosis and identification of pancreatic cancer. This article will review the principles of IVIM imaging and its application in pancreatic diseases, especially in pancreatic cancer diagnosis, the prediction of pathological grade of pancreatic ductal adenocarcinoma, the judgment of lymph node metastasis, and differentiation of pathological classification.